CancerCare Manitoba
 
 
 
News and Announcements

 
Lynch Syndrome Awareness Day March 22, 2017
Genetic testing in Manitoba aids early detection of cancer


March 22, 2017

CancerCare Manitoba joined Minister of Health, Seniors and Active Living Kelvin Goertzen as he officially proclaimed March 22, 2017 as Lynch Syndrome Awareness Day in Manitoba.

Lynch Syndrome is an inherited condition that affects approximately 50 Manitobans each year. Patients with Lynch Syndrome have a 60 per cent chance of developing colorectal cancer. Women with Lynch Syndrome have a 60 per cent risk of developing endometrial cancer.

"Detecting colon cancer at its earliest stage means a 90 per cent survival rate and Lynch Syndrome testing is one more tool towards early detection," said Dr. Sri Navaratnam, president and CEO of CancerCare Manitoba. "The financial support from CancerCare Manitoba Foundation means we can provide this life saving genetic testing to benefit Manitobans."

In Manitoba, colorectal cancer surgery patients aged 70 and under receive testing for Lynch Syndrome. If Lynch Syndrome is detected, cancer monitoring is increased. Because this is a hereditary condition, family members are offered genetic testing. This helps identify their risk of developing cancers and allows them to consider regular screening. This leads to earlier detection and more successful treatments.

"We are so grateful to our donors who support this effort and so many other important initiatives which enable CancerCare Manitoba to do its great work," said Annitta Stenning, president and CEO of CancerCare Manitoba Foundation.

Lynch Syndrome testing is delivered by a partnership between CancerCare Manitoba and Diagnostic Services Manitoba.

Click here to view PDF



World Cancer Day - February 4th 2017

February 2, 2017

World Cancer Day's primary objective is "to get as many people as possible around the globe to talk about cancer? It aims to save millions of preventable deaths each year by raising awareness and education about the disease, pressing governments and individuals across the world to take action."

In 2017 - the incidence of cancer will continue to grow due primarily to our growing and aging population. With the number of people who will be newly diagnosed and those with cancer living longer lives, cancer as a disease will be part of our life story whether it touches us, our family or friends.

We have come a long way over the past decades ? screening, earlier diagnosis and improved treatment of cancer has led to better outcomes and quality of life. In light of this reality, we can approach the disease with optimism and hope that it will not bring death but rather a cure, and if not a cure, then quality of life and living well with the disease. We need to look at cancer differently, to view it with a brighter optimism than it has been viewed in the past.

In 2017 - as healthcare providers and researchers, we will continue our commitment to advancing cancer care. At the same time, we can help to change society?s view of cancer by approaching it with renewed optimism. We can all commit to this ? knowing the diagnosis of cancer cannot be eliminated (yet), but we can be optimistic in the midst of it.

It?s 2017 - on World Cancer Day, tell your story or listen to someone?s story. Make healthy lifestyle choices to reduce the risk of cancer. Take on the CCMB Pedometer Challenge in support of World Cancer Day.

Let?s be bold and say that our goal this year for patients, ourselves, our families and friends, is to live well with cancer - not to die of the disease. As a society, we need to view cancer with a brighter optimism.

Sri Navaratnam,
President and CEO, CancerCare Manitoba


Click Here to view PDF


» External Link

Clinical Practice Guidelines Initiative is pleased to announce the completion of several guideline projects

July 12, 2016

Clinical Practice Guidelines Initiative is pleased to announce the completion of several guideline projects which are now available on CancerCare Manitoba?s (CCMBs) website.

Following are the four newly posted guidelines:

These guidelines can be used by administrators, clinicians and patients to determine the best course of action when decisions about treatment options or care must be made. The ultimate goal is to ease the patient's journey through the cancer experience and keep patients and their families at the centre of care.

CancerCare Manitoba?s website contains all approved Clinical Practice Guidelines (CPGs), Clinical Guides, and Systemic Therapy Summaries (STSs). Information on the development of our Clinical Practice Guidelines and other resources are also available.

Clinical Practice Guidelines and practice tool may be updated periodically. We recommend that practitioners frequently consult the website to ensure they are using the most recent versions.

We would like to extend a sincere thank you to all of the contributors listed in the guidelines for their time and expertise.



Click here to view News Archive